Concepedia

Urszula Grabowska

UG

25

Publications

730

Citations

17

H-Index

1991

Active since

Affiliations

Medivir (Sweden)(Current)

St George's, University of London

Jan Kochanowski University

The University of Texas MD Anderson Cancer Center

Yale Cancer Center

Urszula Grabowska is an author at Medivir (Sweden) specializing in pharmacology, organic chemistry, and natural sciences.

ORCID

Top concepts

Publications per year

1991–2022

25

Publications

25

Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts

K. Fuller, Kevin M. Lawrence, Jade L. Ross et al. · Bone · 2007 · 115 citations

, , +11

The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis

Erik Lindström, Biljana Rizoska, Karin Tunblad et al. · Journal of Translational Medicine · 2018 · 81 citations · Full text

Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice

Lena Svelander, Helena Erlandsson-Harris, Leif Astner et al. · European Journal of Pharmacology · 2009 · 58 citations

, , +12

A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance

Timothy A. Yap, Patricia LoRusso, Deborah J. Wong et al. · Clinical Cancer Research · 2022 · 48 citations · Full text

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Erik Lindström, Biljana Rizoska, Ian Henderson et al. · Journal of Translational Medicine · 2018 · 40 citations · Full text

Rows per page

1–5 of 25